A Phase 1 Study to Investigate the Mechanism of Action of Ipragliflozin

Clinical trial NCT01611363 · COMPLETED

Trial details

NCT number: NCT01611363
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2011-10-27
Primary completion: 2012-02-03
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.